IP Verse

Low Frequency Glatiramer Acetate Therapy

Patent No. EP2630962 (titled "Low Frequency Glatiramer Acetate Therapy") was filed by Yeda Research on Aug 19, 2010. The application was issued on Jun 27, 2018.

Patent Summary

Multiple sclerosis treatment in a human patient suffering from relapsing remitting multiple sclerosis. The treatment involves reducing the frequency of subcutaneous injections of a pharmaceutical composition comprising a therapeutically effective dose of glatiramer acetate to three times over a period of seven days with at least one day between every subcutaneous injection and wherein the pharmaceutical composition further comprises mannitol and has a pH in the range of 5.5-7.0.

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALVOGEN IPCOMar 27, 2019HAMM & WITTKOPP
HEXALMar 27, 2019SCHUST
G L PHARMAMar 26, 2019HAMM & WITTKOPP
SYNTHONMar 26, 2019HAMM & WITTKOPP
GENERICS UK TRADING MYLANMar 25, 2019GILL JENNINGS & EVERY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2630962

YEDA RESEARCH
Application Number
EP13166080A
Filing Date
Aug 19, 2010
Status
Revoked
May 10, 2024
Publication Date
Jun 27, 2018
External Links
Slate, Register , Google Patents